Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Other Working Capital Changes (2020 - 2025)

Journey Medical's Other Working Capital Changes history spans 6 years, with the latest figure at $1.5 million for Q4 2025.

  • For the quarter ending Q4 2025, Other Working Capital Changes fell 33.69% year-over-year to $1.5 million, compared with a TTM value of $4.1 million through Dec 2025, up 59.04%, and an annual FY2025 reading of $2500.0, down 90.5% over the prior year.
  • Other Working Capital Changes for Q4 2025 was $1.5 million at Journey Medical, up from $2500.0 in the prior quarter.
  • The five-year high for Other Working Capital Changes was $2.2 million in Q4 2024, with the low at -$24000.0 in Q2 2021.
  • Average Other Working Capital Changes over 5 years is $244761.2, with a median of $9684.5 recorded in 2022.
  • Year-over-year, Other Working Capital Changes tumbled 125.81% in 2022 and then skyrocketed 4337.5% in 2023.
  • Tracing DERM's Other Working Capital Changes over 5 years: stood at $31000.0 in 2021, then crashed by 125.81% to -$8000.0 in 2022, then skyrocketed by 4337.5% to $339000.0 in 2023, then skyrocketed by 563.72% to $2.2 million in 2024, then tumbled by 33.69% to $1.5 million in 2025.
  • Per Business Quant, the three most recent readings for DERM's Other Working Capital Changes are $1.5 million (Q4 2025), $2500.0 (Q3 2025), and $2500.0 (Q2 2025).